6-K ·Filed May 29, 2026
Notable filing: 6-K
Actionable Insight • Neutral
This is a routine procedural filing with no new financial data or material corporate events. Monitor upcoming Phase 3 trial initiation for ATH434 as the next potential catalyst.
Latest settled — T+20d
PRNAF ▲ 0.00% at T+20d
NEUTRAL call 0.00% · α vs SPY +1.79% · entry $0.0550 → $0.0550
T+1d
0.00%
call 0.00% · α -0.26%
$0.0550
settled 5mo ago
T+5d
0.00%
call 0.00% · α +2.52%
$0.0550
settled 5mo ago
T+20d
0.00%
call 0.00% · α +1.79%
$0.0550
settled 4mo ago
T+60d
Pending
due 2mo ago
Price Chart
Loading chart...
Executive Summary
Alterity Therapeutics filed a 6-K reporting the results of its 2026 Extraordinary General Meeting, where shareholders passed resolutions. The filing is routine and contains no new material financial or operational disclosures beyond confirming the meeting outcome.
Key Facts
- Shareholders passed resolutions at the 29 May 2026 Extraordinary General Meeting
- No specific resolution details or financial figures were disclosed in the filing
- The company is preparing to initiate a Phase 3 pivotal trial in Multiple System Atrophy (MSA)
Financial Impact
No financial figures disclosed
Risk Factors
- No new financial or operational data to assess
- Clinical-stage biotech with no approved products or revenue
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (5 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-018808 |
| Document: athe20260529_6k.htm | 0001437749-26-018808 |
| Document: 0001437749-26-018808-index-headers.html | 0001437749-26-018808 |
| Document: 0001437749-26-018808-index.html | 0001437749-26-018808 |
| Document: 0001437749-26-018808.txt | 0001437749-26-018808 |
14 reports for PRNAF
0% Hit rate @ T+20 Went positive at some point 0 of 3 best @ T+1· 0.00%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 9, 2026 20w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▼ −1.39% | $0.2500 (+354.55%) |
Jun 4, 2026 20w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▲ +1.37% | $0.2500 (+354.55%) |
Jun 3, 2026 20w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▲ +1.00% | $0.2500 (+354.55%) |
May 29, 2026 21w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▲ +1.79% | $0.2500 (+354.55%) |
Apr 30, 2026 25w ago | 6-K | $0.0550 $0.0550 | · 0.00% | ▼ −5.23% | $0.2500 (+354.55%) |
Apr 29, 2026 25w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −6.05% | $0.2500 (+22627.27%) |
Apr 27, 2026 26w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.95% | $0.2500 (+22627.27%) |
Apr 22, 2026 26w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.22% | $0.2500 (+22627.27%) |
Apr 21, 2026 27w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.21% | $0.2500 (+22627.27%) |
Apr 20, 2026 27w ago | 6-K | $0.001100 $0.001100 | · 0.00% | ▼ −4.22% | $0.2500 (+22627.27%) |
Showing 10 of 14
US Market Status
Market Closed — Opens Thu (10h 9m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers